Oct 29, 4:01 PM ET
Alignment Healthcare reported third-quarter 2026 total revenue of $1,358.3 million, up 36.7% year-over-year, and membership of approximately 301,200, up 31.2%. Profit fell, with a net loss of $8.1 million compared with net income of $3.7 million a year earlier, and adjusted EBITDA down 32.8%. The company lowered its full-year 2026 adjusted gross profit and adjusted EBITDA guidance because of higher medical costs, which weighs on shareholders' expectations for profitability.
- Q3 2026 total revenue was $1,358.3 million, up 36.7% year-over-year; net loss was $8.1 million versus net income of $3.7 million a year earlier
- Medical benefits ratio based on adjusted gross profit rose to 89.5%, an increase of approximately 240 basis points year-over-year
- Full-year 2026 adjusted gross profit guidance is no less than $575 million and adjusted EBITDA guidance is no less than $100 million, both lowered; full-year revenue guidance was raised to no less than $5,245 million
- Fourth-quarter 2026 guidance calls for adjusted EBITDA of $(28) million, a loss, on revenue of $1,316 million
Read the filing on SEC.gov ↗
Jul 30, 4:01 PM ET
Alignment Healthcare reported second-quarter 2026 total revenue of $1,335.6 million, up 31.6% year-over-year, and net income of $36.6 million, compared with $15.7 million a year earlier. The company raised the midpoint of all its full-year 2026 guidance metrics, including membership, revenue, adjusted gross profit and adjusted EBITDA.
- Q2 2026 total revenue was $1,335.6 million, up 31.6% year-over-year; health plan membership was about 294,100, up 31.5%.
- Net income was $36.6 million versus $15.7 million; diluted EPS was $0.17 versus $0.07 a year earlier.
- Adjusted EBITDA was $68.1 million, a 5.1% margin and up 48.4% year-over-year.
- Full-year 2026 guidance: revenue $5,195 million to $5,225 million; adjusted EBITDA $145 million to $163 million.
Read the filing on SEC.gov ↗
Apr 30, 4:01 PM ET
Alignment Healthcare reported first-quarter 2026 total revenue of $1,235.2 million, up 33.3% year-over-year, and net income of $11.4 million, compared with a net loss of $9.4 million a year earlier. The company also raised the midpoint of its membership, revenue, adjusted gross profit and adjusted EBITDA guidance for 2026, which shows a higher outlook alongside the profit improvement.
- Total revenue was $1,235.2 million for the quarter ended March 31, 2026, up 33.3% from the prior-year quarter.
- Net income was $11.4 million, versus a $9.4 million net loss in Q1 2025; diluted EPS was $0.05.
- Adjusted EBITDA was $37.9 million, up 87.6% year-over-year; health plan membership was about 284,800, up 30.9%.
- Full-year 2026 revenue guidance is $5.16 billion to $5.205 billion, and adjusted EBITDA guidance is $138 million to $163 million.
Read the filing on SEC.gov ↗
Mar 4, 4:08 PM ET
Alignment Healthcare disclosed an underwritten offering in which a selling stockholder, not the company, sold 13,167,733 shares of common stock through J.P. Morgan Securities LLC. The offering closed on March 4, 2026, and the company said it will receive none of the proceeds, so the deal does not add new shares or cash to the company.
- Underwriting agreement dated March 2, 2026, with J.P. Morgan Securities LLC and the selling stockholder
- 13,167,733 shares of common stock offered by the selling stockholder
- Closing and delivery of shares took place March 4, 2026
- Company will not receive any proceeds from the sale
Read the filing on SEC.gov ↗
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.